Francis Fynn-Thompson, MD

Publications powered by Harvard Catalyst Profiles

1. Atrial pacing in Fontan patients: The effect of transvenous lead on clot burden. Heart Rhythm. 2021 Jun 25. View abstract
2. Life-Threatening Hemoptysis in a Pediatric Referral Center. Crit Care Med. 2021 03 01; 49(3):e291-e303. View abstract
3. Berlin Heart EXCOR and ACTION post-approval surveillance study report. J Heart Lung Transplant. 2021 04; 40(4):251-259. View abstract
4. Resynchronizing Right and Left Ventricles With Right Bundle Branch Block in the Congenital Heart Disease Population. JACC Clin Electrophysiol. 2020 12; 6(14):1762-1772. View abstract
5. Comparison of outcomes following thoracoscopic versus thoracotomy closure for persistent patent ductus arteriosus. Cardiol Young. 2020 Oct; 30(10):1433-1438. View abstract
6. Utilization and Outcomes of Children Treated with Direct Thrombin Inhibitors on Paracorporeal Ventricular Assist Device Support. ASAIO J. 2020 08; 66(8):939-945. View abstract
7. Mitochondrial transplantation for myocardial protection in ex-situ?perfused hearts donated after circulatory death. J Heart Lung Transplant. 2020 Jun 29. View abstract
8. Extracorporeal Membrane Oxygenation Support After Heart Transplantation in Children-Outcomes of a Single Center Cohort. Pediatr Crit Care Med. 2020 04; 21(4):332-339. View abstract
9. Early experience with the HeartMate 3 continuous-flow ventricular assist device in pediatric patients and patients with congenital heart disease: A multicenter registry analysis. J Heart Lung Transplant. 2020 06; 39(6):573-579. View abstract
10. Mortality and Factors Associated With Hemorrhage During Pediatric Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med. 2020 01; 21(1):75-81. View abstract
11. Strategies for pediatric lung transplantation: bridging, listing and surgical technique. Ann Cardiothorac Surg. 2020 Jan; 9(1):51-53. View abstract
12. Donor directed lobar lung transplantation. Ann Cardiothorac Surg. 2020 Jan; 9(1):56-57. View abstract
13. Current evaluation and management of plastic bronchitis in the pediatric population. Int J Pediatr Otorhinolaryngol. 2020 Mar; 130:109799. View abstract
14. Utilization and Outcomes of Children Treated with Direct Thrombin Inhibitors on Paracorporeal Ventricular Assist Device Support. ASAIO J. 2019 Nov 20. View abstract
15. Phenotypic Manifestations of Arrhythmogenic Cardiomyopathy in Children and Adolescents. J Am Coll Cardiol. 2019 07 23; 74(3):346-358. View abstract
16. Successful Combined Bilateral Lung Transplant and Congenital Heart Disease Repair in a Pediatric Patient. Rev Esp Cardiol (Engl Ed). 2019 Oct; 72(10):882-884. View abstract
17. Commentary: Between the devil and the deep blue sea: A new palliation for high-risk neonates with hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2019 08; 158(2):e65-e66. View abstract
18. Heart Transplantation in Adults with Congenital Heart Disease. Methodist Debakey Cardiovasc J. 2019 Apr-Jun; 15(2):145-148. View abstract
19. Outcomes of children supported with an intracorporeal continuous-flow left ventricular assist system. J Heart Lung Transplant. 2019 04; 38(4):385-393. View abstract
20. Dual-Site Ventricular Pacing in Patients With Fontan Physiology and Heart Block: Does it Mitigate the Detrimental Effects of Single-Site Ventricular Pacing? JACC Clin Electrophysiol. 2018 10; 4(10):1289-1297. View abstract
21. Coronary artery compression from epicardial leads: More common than we think. Heart Rhythm. 2018 10; 15(10):1439-1447. View abstract
22. RBC Exposure in Pediatric Extracorporeal Membrane Oxygenation: Epidemiology and Factors Associated With Large Blood Transfusion Volume. Pediatr Crit Care Med. 2018 08; 19(8):767-774. View abstract
23. Delayed Presentation of Traumatic Pericardial Rupture: Diagnostic and Surgical Considerations for Treatment. Heart Surg Forum. 2018 06 14; 21(4):E254-E256. View abstract
24. Mesenteric Artery Growth Improves Circulation (MAGIC) in Midaortic Syndrome. Ann Surg. 2018 06; 267(6):e109-e111. View abstract
25. Comparison of two pediatric cases requiring the use of bivalirudin during cardiopulmonary bypass. Perfusion. 2018 10; 33(7):525-532. View abstract
26. A red cell preservation strategy reduces postoperative transfusions in pediatric heart surgery patients. Paediatr Anaesth. 2018 05; 28(5):450-457. View abstract
27. Liver abnormalities and post-transplant survival in pediatric Fontan patients. Pediatr Transplant. 2017 Dec; 21(8). View abstract
28. Genotype-phenotype-guided medical and surgical intervention in long QT syndrome. HeartRhythm Case Rep. 2018 Jan; 4(1):14-17. View abstract
29. Role of cardiac pacing in congenital complete heart block. Expert Rev Cardiovasc Ther. 2017 Nov; 15(11):853-861. View abstract
30. The Evolution of a Pediatric Ventricular Assist Device Program: The Boston Children's Hospital Experience. Pediatr Cardiol. 2017 Jun; 38(5):1032-1041. View abstract
31. Outcomes following thoracotomy or thoracoscopic vascular ring division in children and young adults. J Thorac Cardiovasc Surg. 2017 08; 154(2):607-615. View abstract
32. Berlin Heart EXCOR use in patients with congenital heart disease. J Heart Lung Transplant. 2017 Nov; 36(11):1209-1216. View abstract
33. 1629: LIQUID FLUOROCARBON LAVAGE FOR AIRWAY THROMBUS AFTER SEVERE HEMOPTYSIS REQUIRING ECMO. Crit Care Med. 2016 Dec; 44(12 Suppl 1):482. View abstract
34. 143: OUTCOMES OF EARLY GRAFT FAILURE IN PEDIATRIC HEART TRANSPLANTATION MANAGED WITH ECMO. Crit Care Med. 2016 Dec; 44(12 Suppl 1):113. View abstract
35. Outcomes of mechanical support in a pediatric lung transplant center. Pediatr Pulmonol. 2017 03; 52(3):360-366. View abstract
36. Transvenous approach to pacemaker lead implantation for sinus node dysfunction after extracardiac lateral tunnel Fontan conduit placement. HeartRhythm Case Rep. 2016 Nov; 2(6):495-498. View abstract
37. Anomalous Aortic Origin of Coronary Arteries: A Single-Center Experience. Semin Thorac Cardiovasc Surg. 2016 Winter; 28(4):791-800. View abstract
38. Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease. J Thorac Cardiovasc Surg. 2016 11; 152(5):1333-1342.e3. View abstract
39. Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement. J Extra Corpor Technol. 2016 Mar; 48(1):39-42. View abstract
40. A Modified EXIT-to-ECMO with Optional Reservoir Circuit for Use during an EXIT Procedure Requiring Thoracic Surgery. J Extra Corpor Technol. 2016 Mar; 48(1):35-8. View abstract
41. Paracorporeal lung assist device in infants and toddlers: Coming of age? Pediatr Transplant. 2016 Mar; 20(2):191-3. View abstract
42. Evolution of Surgical Approaches in the Management of Congenital Tracheal Stenosis: Single-Center Experience. World J Pediatr Congenit Heart Surg. 2016 Jan; 7(1):16-24. View abstract
43. Management of Congenital Tracheal Stenosis. Pediatrics. 2015 Sep; 136(3):e660-9. View abstract
44. Impact of pacing on systemic ventricular function in L-transposition of the great arteries. J Thorac Cardiovasc Surg. 2016 Jan; 151(1):131-8. View abstract
45. Rare Etiology of Cardiogenic Shock in Children: Anomalous Origin of the Left Coronary Artery from the Opposite Sinus with an Intramural Course. J Pediatr Intensive Care. 2015 Sep; 4(3):166-167. View abstract
46. Outcomes of surgery for young children with multivessel pulmonary vein stenosis. J Thorac Cardiovasc Surg. 2015 Oct; 150(4):911-7. View abstract
47. Modified end-to-end anastomosis for the treatment of congenital tracheal stenosis with a bridging bronchus. Ann Thorac Surg. 2015 Jan; 99(1):346-8. View abstract
48. Technical performance score as predictor for post-discharge reintervention in valve-sparing tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg. 2014; 26(4):297-303. View abstract
49. Physician and parent perceptions of prognosis and end-of-life experience in children with advanced heart disease. J Palliat Med. 2015 Apr; 18(4):318-23. View abstract
50. Cardiac surgery capacity in sub-saharan Africa: quo vadis? Thorac Cardiovasc Surg. 2014 Aug; 62(5):393-401. View abstract
51. Aspirin unresponsiveness predicts thrombosis in high-risk pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2014 Sep; 148(3):810-4; discussion 814-6. View abstract
52. The association of carotid artery cannulation and neurologic injury in pediatric patients supported with venoarterial extracorporeal membrane oxygenation*. Pediatr Crit Care Med. 2014 May; 15(4):355-61. View abstract
53. Ventricular assist devices in children: progress with an orphan device application. Circulation. 2014 Apr 08; 129(14):1530-7. View abstract
54. Perinatal outcome in fetuses with heterotaxy syndrome and atrioventricular block or bradycardia. Pediatr Cardiol. 2014 Aug; 35(6):906-13. View abstract
55. Fontan pathway growth: a quantitative evaluation of lateral tunnel and extracardiac cavopulmonary connections using serial cardiac magnetic resonance. Ann Thorac Surg. 2014 Mar; 97(3):916-22. View abstract
56. The use of the Berlin Heart EXCOR in patients with functional single ventricle. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):697-704; discussion 704-5. View abstract
57. Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. J Thorac Cardiovasc Surg. 2014 Jan; 147(1):404-9. View abstract
58. Technical Performance Scores are strongly associated with early mortality, postoperative adverse events, and intensive care unit length of stay-analysis of consecutive discharges for 2 years. J Thorac Cardiovasc Surg. 2014 Jan; 147(1):389-94, 396.e1-396.e3. View abstract
59. The role of cardiac resynchronization therapy for arterial switch operations complicated by complete heart block. Ann Thorac Surg. 2013 Sep; 96(3):904-9. View abstract
60. Antibody depletion for the treatment of crossmatch-positive pediatric heart transplant recipients. Pediatr Transplant. 2013 Nov; 17(7):661-9. View abstract
61. An extracorporeal membrane oxygenation cannulation curriculum featuring a novel integrated skills trainer leads to improved performance among pediatric cardiac surgery trainees. Simul Healthc. 2013 Aug; 8(4):221-8. View abstract
62. Inadequate technical performance scores are associated with late mortality and late reintervention. Ann Thorac Surg. 2013 Aug; 96(2):664-9. View abstract
63. Biventricular conversion after single-ventricle palliation in unbalanced atrioventricular canal defects. Ann Thorac Surg. 2013 Jun; 95(6):2086-95; discussion 2095-6. View abstract
64. Technical performance scores in congenital cardiac operations: a quality assessment initiative. Ann Thorac Surg. 2012 Oct; 94(4):1317-23; discussion 1323. View abstract
65. Quality of life of pediatric cardiac patients who previously required extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2012 Jul; 13(4):428-34. View abstract
66. Extracorporeal membrane oxygenation after stage 1 palliation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1337-43. View abstract
67. Experimental and numeric investigation of Impella pumps as cavopulmonary assistance for a failing Fontan. J Thorac Cardiovasc Surg. 2012 Sep; 144(3):563-9. View abstract
68. Comparison of risk factors and outcomes for pediatric patients listed for heart transplantation after bidirectional Glenn and after Fontan: an analysis from the Pediatric Heart Transplant Study. J Heart Lung Transplant. 2012 Feb; 31(2):133-9. View abstract
69. The addition of a membrane oxygenator to a ventricular assist device in a patient with acute respiratory distress syndrome. J Extra Corpor Technol. 2011 Dec; 43(4):264-6. View abstract
70. Current pharmacologic management of pediatric heart failure in congenital heart disease. Curr Vasc Pharmacol. 2011 Sep; 9(5):619-28. View abstract
71. Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease. Circ Heart Fail. 2011 Nov; 4(6):707-13. View abstract
72. Early postoperative severity of illness predicts outcomes after the stage I Norwood procedure. Ann Thorac Surg. 2011 Aug; 92(2):660-5. View abstract
73. Association of graft ischemic time with survival after heart transplant among children in the United States. J Heart Lung Transplant. 2011 Nov; 30(11):1244-9. View abstract
74. Extracorporeal membrane oxygenation for bridge to heart transplantation among children in the United States: analysis of data from the Organ Procurement and Transplant Network and Extracorporeal Life Support Organization Registry. Circulation. 2011 Jun 28; 123(25):2975-84. View abstract
75. Survival of children requiring repeat extracorporeal membrane oxygenation after congenital heart surgery. Ann Thorac Surg. 2011 Jun; 91(6):1949-55. View abstract
76. The role of surgical therapy for pulmonary vein atresia in childhood. Pediatr Cardiol. 2011 Jun; 32(5):639-45. View abstract
77. Extracorporeal membrane oxygenation support after the Fontan operation. J Thorac Cardiovasc Surg. 2011 Sep; 142(3):504-10. View abstract
78. Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant. 2011 Jan; 30(1):1-8. View abstract
79. Right ventricle and tricuspid valve function at midterm after the Fontan operation for hypoplastic left heart syndrome: impact of shunt type. Pediatr Cardiol. 2011 Feb; 32(2):160-6. View abstract
80. Induction therapy with antithymocyte globulin before reperfusion. Ann Thorac Surg. 2010 Oct; 90(4):1110-4; discussion 1114-5. View abstract
81. Rapid-response extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in children with cardiac disease. Circulation. 2010 Sep 14; 122(11 Suppl):S241-8. View abstract
82. Outcomes of heart transplantation using donor hearts from infants with sudden infant death syndrome. J Heart Lung Transplant. 2010 Nov; 29(11):1226-30. View abstract
83. Intraoperative assessment after pediatric cardiac surgical repair: initial experience with C-arm angiography. J Thorac Cardiovasc Surg. 2010 Jul; 140(1):e1-3. View abstract
84. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis. Circulation. 2010 May 04; 121(17):1926-33. View abstract
85. System survival of nontransvenous implantable cardioverter-defibrillators compared to transvenous implantable cardioverter-defibrillators in pediatric and congenital heart disease patients. Heart Rhythm. 2010; 7(2):193-8. View abstract
86. Preoperative extracorporeal membrane oxygenation as a bridge to cardiac surgery in children with congenital heart disease. Ann Thorac Surg. 2009 Oct; 88(4):1306-11. View abstract
87. Incidence and risk factors for mortality in infants awaiting heart transplantation in the USA. J Heart Lung Transplant. 2009 Dec; 28(12):1292-8. View abstract
88. Long-term results of right ventricular outflow tract reconstruction in neonatal cardiac surgery: options and outcomes. J Thorac Cardiovasc Surg. 2009 Oct; 138(4):911-6. View abstract
89. Permanent atrial pacing lead implant route after Fontan operation. Pacing Clin Electrophysiol. 2009 Jun; 32(6):779-85. View abstract
90. Biventricular repair in patients with heterotaxy syndrome. J Thorac Cardiovasc Surg. 2009 Feb; 137(2):371-379.e3. View abstract
91. Waiting list mortality among children listed for heart transplantation in the United States. Circulation. 2009 Feb 10; 119(5):717-727. View abstract
92. Video-assisted thoracoscopic cardiac denervation: a potential novel therapeutic option for children with intractable ventricular arrhythmias. Ann Thorac Surg. 2008 Nov; 86(5):1620-5. View abstract
93. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009 Jan; 20(1):58-65. View abstract
94. Measurement of technical performance in surgery for congenital heart disease: the stage I Norwood procedure. J Thorac Cardiovasc Surg. 2008 Oct; 136(4):993-7, 997.e1-2. View abstract
95. Clinical outcomes of Fontan conversion surgery with and without associated arrhythmia intervention. Int J Cardiol. 2009 Nov 12; 137(3):260-6. View abstract
96. Survival and clinical course at Fontan after stage one palliation with either a modified Blalock-Taussig shunt or a right ventricle to pulmonary artery conduit. J Am Coll Cardiol. 2008 Jul 01; 52(1):52-9. View abstract
97. Surgical outcome for patients with the mitral stenosis-aortic atresia variant of hypoplastic left heart syndrome. J Thorac Cardiovasc Surg. 2008 Feb; 135(2):339-46. View abstract
98. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann Thorac Surg. 2007 Aug; 84(2):581-5; discussion 586. View abstract
99. Pediatric ventricular assist devices. Pediatr Cardiol. 2007 Mar-Apr; 28(2):149-55. View abstract
100. Measurement of technical performance in congenital heart surgery: a pilot study. Ann Thorac Surg. 2007 Jan; 83(1):179-84. View abstract
101. Cardiac resynchronization therapy is associated with improved systolic ventricular function in pediatrics and congenital heart disease. Heart Rhythm. 2006; 3(5):S172. View abstract
102. Successful implantation of a Berlin heart biventricular assist device in a failing single ventricle. J Thorac Cardiovasc Surg. 2006 Jun; 131(6):1407-8. View abstract
103. Berlin Heart: Biventricular Assist Device. 2005. View abstract
104. Methods for reduction of sternal wound infection. Semin Thorac Cardiovasc Surg. 2004; 16(1):77-80. View abstract
105. Management of tracheobronchial and esophageal trauma. The Trauma Handbook of the Massachusetts General Hospital. 2004; 314-327 . View abstract
106. Quantitative analysis of the degree of irreversible deformation of F cells and non-F cells and its relationship to cell density in sickle cell disease. Exp Hematol. 1994 Oct; 22(11):1058-63. View abstract
107. Dynamics of Health Care in Ghana: A model for Africa. 1993. View abstract